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The Spinal Muscular Atrophy Disease Gene Product,
SMN, and Its Associated Protein SIP1
Are in a Complex with Spliceosomal snRNP Proteins
Qing Liu, Utz Fischer, Fan Wang, in rRNA processing, and with several other RNA-binding
proteins (Liu and Dreyfuss, 1996). By use of monoclonaland Gideon Dreyfuss*
antibodies to SMN, we have also found that it has aHoward Hughes Medical Institute
unique cellular localization. SMN shows general local-Department of Biochemistry and Biophysics
ization in the cytoplasm and is particularly concentratedUniversity of Pennsylvania School of Medicine
in several prominent nuclear bodies called gems. GemsPhiladelphia, Pennsylvania 19104-6148
are novel nuclear structures. They are related in number
and size to coiled bodies and are usually found in close
proximity to them (Liu and Dreyfuss, 1996). Coiled bod-Summary
ies are prominent nuclear bodies found in widely diver-
gent organisms, including plant and animal cells (Boh-Spinal muscular atrophy (SMA), one of the most com-
mann et al., 1995a; reviewed in Gall et al., 1995). Coiledmon fatal autosomal recessive diseases, is character-
bodies contain the spliceosomal U1, U2, U4/U6, and U5ized by degeneration of motor neurons and muscular
snRNPs, U3 snoRNAs, and several proteins, includingatrophy. The SMA disease gene, termed Survival of
the specific marker p80-coilin, fibrillarin, and NOP140Motor Neurons (SMN), is deleted or mutated in over
(Bohmann et al., 1995a, and references therein; Gall et98% of SMA patients. The function of the SMN protein
al., 1995). Expression of p80-coilin mutants and micro-is unknown. We found that SMN is tightly associated
scopic observations suggests a close association be-with a novel protein, SIP1, and together they form a
tween coiled bodies and the nucleolus (Raska et al.,specific complex with several spliceosomal snRNP
1990; Andrade et al., 1991; Bohmann et al., 1995b). How-proteins. SMN interacts directly with several of the
ever, the specific functions of coiled bodies are notsnRNP Sm core proteins, including B, D1±3, and E.
clear. Current ideas propose that coiled bodies may beInterestingly, SIP1 has significant sequence similarity
involved in processing, sorting, and assembly of snRNAswith Brr1, a yeast protein critical for snRNP biogene-
and snoRNAs in the nucleus. The close association ofsis. These findings suggest a role for SMN and SIP1
gems and coiled bodies raises the possibility that thein spliceosomal snRNP biogenesis and function and
SMN protein and gems are also involved in the pro-provide a likely molecular mechanism for the cause
cessing and metabolism of small nuclear RNAs (Liu andof SMA.
Dreyfuss, 1996).
The biogenesis of snRNPs is a complex, multistepIntroduction
process (DeRobertis, 1983; Fisher et al., 1985; Mattaj,
1988; Feeney et al., 1989; Neuman de Vegvar and Dahl-Spinal muscular atrophy (SMA) is characterized by de-
berg, 1990; Zieve and Sauterer, 1990). Spliceosomalgeneration of anterior horn cells of the spinal cord, lead-
snRNAs that contain the Sm site (a short, single-stranded,ing to progressive symmetrical limb and trunk paralysis
eight-to-ten-nucleotide uridine-rich sequence) are first
and muscular atrophy. It is the second most common
exported to the cytoplasm, where they associate with
fatal autosomal recessive disorder after cystic fibrosis
the Sm proteins (B, B9, D1, D2, D3, E, F, and G) (Mattaj
and the most common genetic cause of childhood mor-
and DeRobertis, 1985). Next, in a reaction that requires
tality (Roberts et al., 1970; Pearn, 1973, 1978; Czeizei
the assembled Sm core domain (comprising the Sm
and Hamular, 1989). Childhood spinal muscular atro-
proteins bound to the Sm site), the 7-methylguanosine
phies are divided into severe (type I, Werdnig-Hoffman
(m7G) cap of the snRNAs is hypermethylated to yield
disease) and mild forms (type II and III) according to the 2,2,7-trimethylguanosine (m3G) (Mattaj, 1986). In addi-age of onset and the severity of the disease (Munsat,
tion, varying numbers of nucleotides are trimmed from
1991; Crawford and Pardo, 1996). The Survival of Motor
the 39 end of several of the snRNAs. Proper Sm core
Neurons (SMN) gene (Lefebvre et al., 1995) has been
assembly, cap hypermethylation, and 39-end processing
shown to be the SMA disease gene, and it is deleted or are important for nuclear import of the assembled
mutated in over 98% of SMA patients (Bussaglia et al., snRNP particles (Fischer and LuÈ hrmann, 1990; Hamm et
1995; Chang et al., 1995; Cobben et al., 1995; Hahnen al., 1990). Finally, just before or after the nuclear import,
et al., 1995, 1996; Lefebvre et al., 1995; Rodrigues et many internal nucleotides are modified and more than
al., 1995; Velasco et al., 1996; Lefebvre et al., 1997). The 30 snRNP-specific proteins associate with the individual
SMN gene encodes a protein of 296 amino acids with snRNP precursors to complete their biogenesis (Mattaj,
a calculated molecular mass of 32 kDa (Lefebvre et al., 1988; LuÈ hrmann et al., 1990; Neuman de Vegvar and
1995). The sequence of the protein does not show any Dahlberg, 1990; Zieve and Sauterer, 1990). However, the
significant homology to any other protein in the data- detailed mechanism of how the Sm core proteins and
bases. the snRNP-specific proteins form functional assembled
Recently, in the course of studies of the functions snRNPs is not clear.
of heterogeneous nuclear ribonucleoproteins (hnRNPs) Here we report the molecular cloning and character-
(Dreyfuss et al., 1993), we found that the SMN protein ization of a protein designated SIP1 (for SMN-interacting
interacts with fibrillarin, an RNA-binding protein involved protein 1) that forms a stable heteromeric complex with
SMN in vivo and in vitro. SIP1 is a novel protein, and it
colocalizes with SMN in gems and in the cytoplasm. We*To whom correspondence should be addressed.
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Figure 1. Amino Acid Sequence Alignment of
Human SIP1 (huSIP1) and Xenopus SIP1
(XeSIP1)
Also shown is the amino acid sequence align-
ment of SIP1 with the S. cerevisiae Brr1 pro-
tein. The boxes indicate identical amino
acids, and the borderless gray boxes indicate
similar amino acids.
have isolated a large protein complex (ca. 300 kDa) that interacts with SMN, which we term SIP1. The predicted
amino acid sequence of SIP1, along with the sequencecontains both SMN and SIP1 together with several
spliceosomal snRNP proteins. We have found that SMN of the Xenopus laevis homolog that we isolated as de-
scribed below, is presented in Figure 1. SIP1 encodesinteracts directly with several spliceosomal snRNP core
Sm proteins, including B/B9 and the D and E group a protein of apparently 279 amino acids (including the
potential 24 amino acids predicted by the EST se-proteins. Interestingly, we found that SIP1 has limited
but significant similarity to the recently described yeast quence) with a calculated molecular mass of 32 kDa
and pI of 5.3.protein Brr1, which has been shown to play a role in the
production of spliceosomal snRNPs (Noble and Guthrie, To examine the interaction of SIP1 with SMN and
to characterize SIP1 further, we generated monoclonal1996a, 1996b). SMA may, therefore, be the result of
a genetic defect in spliceosomal snRNP biogenesis in antibodies to the SIP1 protein by immunizing mice with
purified recombinant 6His-tag SIP1 (starting with themotor neurons.
second methionine). Two of these monoclonals, 2E17
and 2S7, were further characterized in detail and shownResults
to react with SIP1 specifically by both immunoprecipita-
tion and Western blotting (data not shown). 2E17reactedSIP1, a Novel SMN-Interacting Protein
Using SMN as a bait in a yeast two-hybrid screen of a also with a protein of similar size in Xenopus, and using
this as the primary antibody, we screened a XenopusHeLa cDNA library, we isolated ten independent partial
cDNA clones with insert sizes from 1 kb to 1.3 kb, all oocyte cDNA library and obtained the Xenopus homolog
of SIP1. The predicted amino acid sequence of Xenopusof which contained the same open reading frame. The
longest of these clones, designated 7-10, contained an SIP1 is presented in Figure 1. Interestingly, all of the
eight clones we obtained from the library screen lackinsert of 1.3 kb that was completely sequenced. Using
the BLAST search program to search the GenBank data- the first 24 amino acids that are potentially found in the
human EST clone. Xenopus SIP1 is highly similar tobase, an EST (clone #Z64761) (Cross et al., 1994) that
is identical to the 59 end of clone 7-10 and extends human SIP1, the two proteins being z90% identical in
amino acid sequence. BLAST searches did not revealfurther upstream was identified. Conceptional transla-
tion of this cDNA revealed another potential methionine significant homology to any other protein in the data-
bases. However, we subsequently noticed a yeast pro-24 amino acids upstream of the first methionine of clone
7-10. Immediately upstream of this methionine is a stop tein, termed Brr1, that has significant similarity to SIP1
(Figure 1), and this is discussed below (see Discussion).codon. We are not certain which methionine is the actual
initiation methionine for the full-length cDNA. The
39-untranslated region is very AU-rich and contains a SIP1 Interacts with SMN In Vitro and In Vivo
In order to confirm the yeast two-hybrid results, weputative polyadenylation site AAUAAA. Thus, this is
likely the full-length cDNA clone for the novel protein that tested for interaction of SIP1 with SMN both in vitro and
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IP), 2S7 readily detects SIP1 in the 2B1 immunoprecipi-
tates, indicating that SIP1 is coimmunoprecipitated with
SMN. In a reciprocal experiment, the SMN protein could
also be coimmunoprecipitated by the anti-SIP1 mono-
clonal antibody 2S7 (Figure 2B, lane 2S7 IP). This result
was confirmed with other monoclonal antibodies to
SMN and to SIP1. As shown in Figure 2 and from data
not shown, there is no crossreactivity between the anti-
SMN and anti-SIP1 antibodies. These results indicate
that SMN and SIP1 are associated in vivo and can be
coimmunoprecipitated by either anti-SMN or anti-SIP1
antibodies.
Further indication of the existence invivo of a complex
containing both SIP1 and SMN was obtained from gel
filtration experiments. HeLa nuclear and cytoplasmic
S100 extracts were fractionated on a high performance
gel filtration column, TSK-GEL G3000-SW, and each
fraction was subjected to SDS-PAGE. SMN and SIP1
were detected in the column fractions by immunoblot-
ting with specific monoclonal antibodies. Figure 2C
shows the results of the cytoplasmic fractionation. SMN
and SIP1 comigrate as a peak of ca. 300 kDa, suggesting
that they are part of a large macromolecular complex.
The observed size suggests that this complex contains
either multiple copies of the SMN and SIP1 proteins or
additional components. This complex is very stable, as
it resists dissociation by 4 M urea, and it is observed in
both the nuclear and cytoplasmic fractions.
Figure 2. SIP1 Interacts with SMN In Vitro and In Vivo
(A) SIP1 interacts with GST-SMN in vitro. The interaction is resistant
to a 1 M salt (NaCl) wash. Under the same conditions, SIP1 does SIP1 and SMN Colocalize in Gems in the Nucleus
not bind to GST alone even at low salt (200 mM NaCl) concentration. and in the Cytoplasm
(B) SIP1 and SMN are associated in vivo. Immunoprecipitation from Indirect immunofluorescence microscopy using the
total HeLa extract was done with monoclonal antibodies 2B1 against
monoclonal antibodies 2E17 and 2S7 was performed onSMN and 2S7 against SIP1. The immunoprecipitated proteins were
HeLa cells to determine the cellular localization of SIP1.analyzed by Western blot using 2S7 and 2B1, respectively (lane 2B1
Figures 3A and 3B show, by standard light microscopyIP and lane 2S7 IP).
(C) SMN and SIP1 form a complex of ca. 300 kDa or more in the immunofluorescence, that SIP1 is found throughout the
cytoplasm. HeLa cytoplasmic S100 extract was fractionated on a cytoplasm and also displays intense staining of promi-
G3000-SW column. The fractions were analyzed by SDS-PAGE, and nent discrete bodies in the nucleus. This pattern is very
the SMN and SIP1 proteins were detected by Western blot.
similar to that seen for the SMN protein (Liu and Drey-
fuss, 1996), except that the nucleoplasmic staining of
SIP1 is somewhat stronger than that seen for SMN.
In order to determine if the intensely staining nuclearin HeLa cells in vivo. For the in vitro binding assay,
SMN was expressed as a fusion protein with glutathione structures are gems or coiled bodies, we performed
double-label laser confocal immunofluorescence exper-S-transferase (GST), and SIP1 was produced and la-
beled with [35S]methionine by in vitro transcription and iments using antibodies against p80-coilin (Figure 3C),
fibrillarin (Figure 3D), snRNP proteins (Y12, Figure 3E)translation in rabbit reticulocyte lysate. Purified GST or
GST-SMN fusion proteins immobilized on glutathione- found in coiled bodies, and SMN (Figure 3F) found in
gems. Figures 3C±3E show the double labeling with theSepharose were incubated with labeled SIP1 protein.
Following washing at various salt concentrations (200 coiled body markers and with 2S7. The nuclear struc-
tures that contain SIP1 are clearly different from coiledmM to 1 M), bound proteins were dissociated by boiling
in SDS-containing sample buffer,and the eluted material bodies, but the two bodies are, in most cases, closely
associated. However, the staining with the anti-SIP1was analyzed by SDS-PAGE. As shown in Figure 2A,
full-length SIP1 bound specifically to immobilized GST- monoclonal antibody 2S7 and a rabbit serum raised
against exon 7 of SMN show that SMN and SIP1 com-SMN but not to GST alone. This binding appears to
be very avid because it is not disrupted at 1 M NaCl. pletely colocalize in gems (Figure 3F). The weak signal in
the cytoplasm makes it impossible to determine whetherImmunoprecipitation experiments were performed to
examine if SMN and SIP1 interact in vivo. Anti-SMN SMN and SIP1 also completely colocalize in the cyto-
plasm. However, we believe this is very likely becausemonoclonal antibody 2B1 (Liu and Dreyfuss, 1996) was
used to immunoprecipitate SMN from total HeLa cell of the tight association of SMN with SIP1 described
above (see also accompanying paper, Fischer et al.,extract. The immunoprecipitates were then resolved by
SDS-PAGE and immunoblotted with monoclonal anti- 1997 [this issue of Cell]). The colocalization of SMN
with SIP1 further supports the conclusion that these twobody 2S7 against SIP1. As shown in Figure 2B (lane 2B1
Cell
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Figure 3. The SIP1 Protein Colocalizes with
SMN in Gems
(A) Light microscopic image of indirect immu-
nofluorescence experiment on HeLa cells us-
ing monoclonal antibody 2S7 against the
SIP1 protein. Note the general cytoplasmic
staining and discrete nuclear structures.
(B) Phase contrast image of the same field
as in (A).
(C±E) Superimposed laser confocal images
of double-label immunofluorescence micros-
copy experiments using antibodies against
SIP1 (green) and antibodies against coiled
body markers, p80-coilin ([C], red), fibrillarin
([D], red), and anti-Sm antibody Y12 ([E], red).
(F) The superimposed confocal images of
double-label immunofluorescence micros-
copy experiments using monoclonal antibody
against SIP1 (green) and a rabbit polyclonal
serum raised against exon 7 of the human
SMN protein (red). Colocalization of green
and red results in yellow color.
proteins exist as a complex in the cell. SIP1 is thus the deoxycholate-containing buffer and to a high salt wash
(500 mM NaCl). As a reference for these immunoprecipi-second constituent of gems described so far.
tations (and for reasons discussed below), we also in-
cluded a lane showing an immunoprecipitation with theThe SMN±SIP1 Complex Contains Spliceosomal
snRNP Proteins monoclonal antibody Y12 against the Sm proteins com-
mon to spliceosomal snRNPs (Figure 4A, lane Y12) (Ler-The observation that SMN and SIP1 are in a complex
of ca. 300 kDa prompted us to search for other protein ner and Steitz, 1979; Lerner et al., 1981). To characterize
further this complex, we used two-dimensionalnonequi-components in this complex. To do this, we carried
out immunoprecipitations using anti-SMN and anti-SIP1 librium pH gradient gel electrophoresis (NEPHGE). Fig-
ure 4B shows the major proteins that are specificallymonoclonal antibodies from 35S-labeled HeLa cell ly-
sates, and the immunoprecipitated proteins were then found in the anti-SMN (2B1) isolated complex but not
in control (SP2/0), and these are labeled as SIP1, SIP2,analyzed by SDS-PAGE. As shown in Figure 4A, similar
patterns were obtained with anti-SMN and anti-SIP1 SIP3, and SIP4. A group of basic, low molecular weight
proteins in the anti-SMN immunoprecipitate show theantibodies. Several proteinscan bespecifically coimmu-
nopurified by anti-SMN and anti-SIP1 antibodies. Be- same pattern as some of theSm proteins in immunopuri-
fied snRNPs. For directcomparison, Y12 immunoprecip-sides SMN and SIP1 proteins, there is a prominent dou-
blet at z97 kDa, a group of proteins of z28 kDa, and a itate from HeLa nuclear fractions was analyzed in paral-
lel, and U1A, Sm B/B9, D1±3, E, F, and G proteins ofgroup of proteins of z15 kDa. This protein complex is
quite stable, since it is resistant to SDS/Triton X100/ snRNPs migrate in exactly the same pattern as those
A Complex of SMN, SIP1, and snRNP Proteins
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Figure 4. Immunoprecipitation of SMN- and SIP1-Containing Complexes with Monoclonal Antibodies against SMN and SIP1
(A) Immunoprecipitation using monoclonal antibodies 2B1 (lane 2B1) and 2E17 (lane 2E17) from [35S]methionine-labeled HeLa total cell extract
shows a similar pattern. Control antibody Y12 immunoprecipitates Sm proteins and some snRNP-specific proteins (lane Y12), while SP2/0
shows the background of immunoprecipitation (lane SP2/0).
(B) Two-dimensional nonequilibrium pH gradient gel electrophoresis (NEPHGE) analysis of SMN-immunoprecipitated complex (2B1 panel)
and the Sm-immunoprecipitated complexes containing core Sm proteins and some U snRNP-specific proteins immunoprecipitated with
monoclonal antibody Y12 from HeLa nuclear fractions (Y12 panel). The dashed boxes indicate background proteins that are also seen in
control SP2/0 immunoprecipitations (data not shown).
proteins in the SMN complex. Immunoblotting experi- B/B9 and also one or several of the Sm D proteins. When
the same experiments were done with in vitro translatedments with monoclonal antibodies against the U1
snRNP-specific protein U1A and the anti-Sm mono- SIP1, we did not detect any specific binding of SIP1 to
snRNP proteins, although, in the same assay, SIP1 bindsclonal antibody Y12 confirmed that these proteins are
indeed the spliceosomal snRNP proteins. Immunopre- strongly to recombinant SMN protein (data not shown).
These findings suggest that the association of SMN withcipitations with Y12 starting with either total HeLa ex-
tract or from nucleoplasm also showed that SMN and snRNPs occurs via direct protein±protein interaction be-
tween SMN and Sm B/B9 and one or more of the DSIP1 could be detected in Y12 immunoprecipitates by
immunoblotting (data not shown). The immunoprecipita- group proteins, although we cannot entirely exclude the
possibility that some component in the rabbit reticulo-tions shown in Figure 4 were carried out using nucleo-
plasm as the starting material. Similar results, although cyte lysate mediates this interaction. To study this fur-
ther and to examine the binding in solution to other Smwith considerably higher background, were obtained
from cytoplasmic or whole cell extracts, and prediges- proteins, we used in vitro translated and 35S-labeled Sm
proteins B, D1, D2, D3, E, F, and G and tested theirtion with RNases did not reduce the signal (data not
shown). This suggests the SMN±SIP1±Sm protein com- ability to bind to recombinant GST-SMN fusion protein
immobilized on glutathione-Sepharose beads (Lehmeierplexes are found both in the nucleus and in the cyto-
plasm. Though we have not been able to determine et al., 1994; Herrmann et al., 1995; Raker et al., 1996).
As shown in Figure 5B, all Sm proteins except for F anddefinitively whether the immunoprecipitated complexes
contain snRNAs (the resistence of the complexes to G bound efficiently to GST-SMN, whereas there was
no detectable binding to GST alone. However, similarRNase digestion does not preclude this possibility, as
the RNAs may not be fully accesible), experiments de- experiments failed to detect any interaction between
the Sm proteins and SIP1 (data not shown).scribed in Fischer et al. (1997) demonstrate that SMN
and SIP1 can immunoprecipitate labeled snRNAs.
The SMN Protein Interacts with Sm B/B9, SMN Contains Two Distinct Binding Sites
for the Sm Proteins and for SIP1Sm D, and Sm E Proteins Directly
Most of the snRNAs in snRNP complexes are resistant The experiments described above showed that SMN
interacts with both SIP1 and several of the Sm proteins,to RNase digestion and this, therefore, makes it difficult
to determine if the SMN±SIP1±snRNP protein com- and we therefore tested whether binding of SMN to Sm
proteins and SIP1 was mutually exclusive or could occurplexes result from protein±protein or protein±RNA inter-
actions. To investigate whether SMN interacts with at the same time via two different binding sites on the
SMN protein.To analyze this, peptides were synthesizedsnRNP proteins directly, we used in vitro translated
[35S]methionine-labeled SMN in a far-Western blot assay corresponding to the two most conserved regions of
SMN (determined by comparing the sequence of theto probe SDS-PAGE-resolved proteinsof purified snRNPs.
The protein composition of purified snRNPs is shown human SMN with that of Xenopus SMN, which we cloned
and sequenced; data not shown) located at the N termi-in Figure 5 (lane snRNPs). The result of probing these
proteins with [35S]SMN (Figure 5, lane [35S]SMN) indi- nus (aa 13±44) and the C terminus (aa 240±267), assum-
ing that these domains may be involved in importantcates that SMN binds specifically and directly to Sm
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SIP1 to SMN, while the binding of Sm B was unaffected
(Figure 5C). In contrast, BSA-P2 strongly inhibited the
binding of Sm B to SMN but had no effect on the binding
of SMN to SIP1. As a nonspecific control, we used BSA
coupled toHIV1 Rev NES(BSA-Ctrl) (Fischer et al., 1995),
and this, in contrast, had no effect on the binding of
SMN to either protein (Figure 5C). Additional experi-
ments showed that the corresponding domains of SMN
are alone sufficient for binding to SIP1 and Sm B (data
not shown). Similar results were obtained for the other
Sm proteins. Thus, these experiments define two inde-
pendent binding sites for SIP1 and the Sm proteins on
SMN. SMN may therefore serve as a critical bridge be-
tween theSm proteins and SIP1 and nucleate the forma-
tion of the SMN±SIP1±Sm complex.
Discussion
Molecular characterization of the protein product of the
gene that causes SMA, SMN, has led to the discovery
of a novel nuclear structure, called gem, in which SMN
is concentrated (Liu and Dreyfuss, 1996). Gems appear
by size, number, and proximity to be related to coiled
bodies, another subnuclear structure of unknown func-
tion. Previous studies suggested that gems, like coiled
bodies, are involved in RNA metabolism, and, consistent
with this, SMN was found to interact with several RNA-
binding proteins and possibly also with RNA directly
(Liu and Dreyfuss, 1996; Liu et al., 1996). However, the
specific function of SMN remained obscure. Here, in a
yeast two-hybrid screen using SMN as the bait, we haveFigure 5. The SMN Protein Can Bind to Sm B/B9, D1±3, and E Pro-
identified a novel protein, SIP1. SIP1 forms a stableteins Directly
complex with SMN in vivo and in vitro, and it colocalizes(A) Purified snRNP proteins were analyzed on SDS-PAGE (lane
with SMN in gems and in the cytoplasm. Several linessnRNPs) and transferred to a nitrocellulose membrane. The mem-
brane was then probed with 2 3 106 cpm of in vitro translated 35S- of evidence suggest that SMN and SIP1 function as a
labeled SMN protein. After washing away the nonspecific binding complex in vivo. The interaction of SMN and SIP1 in
proteins, the membrane was exposed to an X-ray film (lane vitro is resistant to 1 M NaCl, suggesting that they inter-
[35S]SMN). We can not distinguish among the three D proteins in
act avidly. A similarly strong interaction is found forthis gel system. SMN has two distinct binding domains for the Sm
several other protein complexes, such as the FMR1/proteins and SIP1, respectively.
FXR family protein (Zhang et al., 1995) and the Sm E, F,(B) In vitro translated [35S]-labeled Sm proteins B, D1, D2, D3, E, F,
and G were incubated for 30 min at 48C with GST-SMN immobilized G complex (Raker et al., 1996). The 300 kDa complex
on glutathione-Sepharose beads. The beads were then washed six that contains SMN and SIP1 is stable even in 4 M urea.
times with binding buffer (see Experimental Procedures). Proteins Also, SMN and SIP1 can be coimmunoprecipitated with
that remained bound to the beads were eluted by boiling in SDS-
specific monoclonal antibodies. Further, a yeast two-PAGE sample buffer and analyzed by SDS-PAGE followed by fluo-
hybrid screen using SIP1 as the bait under high strin-rography.
gency conditions (15 mM 3-aminotriazole) isolated from(C) In vitro translated [35S]-labeled Sm B and SIP1 proteins were
mixed, and binding to GST-SMN was carried out as described above a human library only SMN clones (Q. L. and G. D., unpub-
either in the absence (-) or presence of BSA-coupled peptides corre- lished data). Finally, SMN and SIP1 colocalize in gems,
sponding to amino acids 13±44 (P1) or 240±267 (P2) of human SMN suggesting that these two proteins function together.
or to an unrelated control sequence from HIV-1 Rev NES (ctrl). After
As loss or mutation of SMN leads to motor neuron de-washing the beads, bound proteins were eluted by boiling in SDS-
generation, itwill be interesting to determine if mutationsPAGE sample buffer and analyzed by SDS-PAGE followed by fluo-
in or loss of SIP1 also causes neurodegenerative dis-rography.
ease.Chromosomal mapping and experiments to gener-
ate SIP1-null mutation in the mouse and determine their
effect are under way.protein±protein interactions. These regions are also con-
served in several candidate SMN orthologs identified in Immunopurification of the 300 kDa complex showed
that it contains, besides SMN and SIP1, spliceosomaldivergent organisms (Talbot et al., 1997). These peptides
were then coupled to BSA (termed BSA-P1 and BSA- snRNP core proteins including B/B9, D, E, F, and G, the
snRNP-specific protein U1A, and several other unidenti-P2, respectively) and used as competitors in the binding
assays for SMN to SIP1 and the Sm proteins. Without fied proteins. Furthermore, we found that SMN interacts
directly with several spliceosomal snRNP core Sm pro-competitors, SIP1 and Sm B bound to GST-SMN (Figure
5C). However, BSA-P1 completely abolished binding of teins, including B/B9, D1±3, and E. These data suggest
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manipulation of yeast and the library screening were carried outthat the SMN±SIP1 complex plays an important role in
according to the conditions suggested by the manufacturer. In brief,spliceosomal snRNP biogenesis and/or function. Al-
the coding region of SMN was cloned into the pGBT9 vector. Thethough BLAST searches of sequence databases with
S. cerevisiae HF7c reporter strain was first transformed with pGBT9-
the SIP1 protein did not find significant homology to any derived SMN construct and subsequently with the HeLa cDNA li-
other proteins, we noticed by visual inspection limited brary. Approximately 6 3 106 transformants were seeded on eight
but significant homology between SIP1 and the yeast 150 mm plates containing synthetic medium lacking histidine, leu-
cine, and tryptophan. His1 colonies were grown on synthetic me-protein Brr1 (Noble and Guthrie, 1996a, 1996b). The se-
dium plates lacking leucine and tryptophan and then assayed forquence alignment of the two proteins is shown in Figure
b-galactosidase activity by filter assay as described by the manufac-1. Brr1 has been shown to be involved in snRNP biogen-
turer. Of 6 million transformants screened, 146 were His1 LacZ1esis in Saccharomyces cerevisiae. Deletion of Brr1
colonies. These positives fell into ten groups. One of these groups
causes destabilization of newly synthesized spliceoso- has ten independent cDNA clones that all encode identical se-
mal U2 snRNA, and Brr1 interacts genetically with the quences of SIP1. The library plasmid was recovered from these
yeast Sm D1 protein (Noble and Guthrie, 1996b). Search- clones into the Escherichia coli HB101 strain. True positive clones
were confirmed by their ability to transactivate HIS3 and LacZ re-ing theyeast genome sequence for possible SMN homo-
porters when cotransforming HF7c with pGBT9 containing SMN.logs has not identified any proteins with significant simi-
larity. However, if Brr1 is the yeast homolog of vertebrate
Production of Monoclonal Antibodies to SIP1SIP1, one would expect that computer searches would
Anti-SIP1 antibodies 2S7 and 2K9 were prepared by immunizing
also not be able to pick up the homology between the Balb/C mice with His6-tag SMNprotein purified from nickel chelation
yeast SMN and the human SMN. It is also possible that chromatography using a Novagen His-Bind buffer kit. Hybridoma
there is no SMN homolog in S. cerevisiae and that al- production and screening and ascites fluid production were per-
though SIP1 functions with SMN in metazoan snRNP formed as previously described (Choi and Dreyfuss, 1984).
biogenesis, Brr1 fulfills the functions of both in yeast.
Production of Proteins In VitroTo find out if SIP1 and Brr1 are functional homologs, it
The [35S]-labeledproteins wereproduced by an in vitro transcription±will be interesting to see if human SIP1 can rescue the
translation reaction (Promega Biotech) in the presence of [35S]methi-phenotype of Brr1 deficiency in yeast. SMN, because it
onine (Amersham). His6-SMN fusion protein was expressed from a
can interact with SIP1 and with the spliceosomal snRNP pET bacterial expression system in the E. coli strain BL2l(DE3)pLysS
Sm proteins via different domains, can potentially serve and purified using nickel chelation chromatography using the same
as the key bridging component to bring together the kit as described above. GST-SMN fusion protein was expressed
from a GST expression vector pGEX-5X-3 (Pharmacia) in the E. colivarious components of the complex. It is therefore par-
strain BL21 and purified using glutathione-Sepharose provided byticularly interesting to note that many SMA patients have
Pharmacia Biotech according to the manufacturer's protocol.deletions or point mutations encompassing exons 6 and
7 of SMN, the region we show here to be involved in
In Vitro Protein-Binding Assays
binding of SMN to the Sm proteins. Several missense Purified GST or GST fusion protein (2 mg) was incubated with 106
mutations in the the region of SMN corresponding to cpm of the in vitro translated protein product and 25 ml of glutathi-
the P2 peptide have recently been described (Hahnen one-Sepharose beads in 500 ml of binding buffer (50 mM Tris-HCl
[pH 7.5], 2 mM EDTA, 0.1% NP40, 2 mg/ml leupeptin and pepstatin A,et al., 1996), and it will be of interest to determine if such
and 0.5% aprotinin) containing different salt (NaCl) concentrations.mutations exhibit altered binding to the Sm proteins.
Following incubation for 30 min at 48C, the resin was pelleted,Important information about the functions of the SMN±
washed with binding buffer, and the bound fraction was eluted bySIP1-containing complex will also likely come from the
boiling in SDS-PAGE sample buffer, analyzed by SDS-PAGE, and
characterization of the unidentified proteins SIP2, SIP3, visualized by fluorography. For the binding experiments described
and SIP4. in Figure 5, 200 to 300 ng of GST or GST-SMN fusion protein was
Together, these observations provide an important bound to 30 ml of glutathione-Sepharose beads dissolved in PBS
advance in understanding the molecular mechanism of (pH 7.4) and incubated with 35S-labeled in vitro translated protein
(ca. 1 3 105 to 2 3 105 cpm/assay) for 30 min at 48C. The beadsSMA as well as in the fundamental process of spliceoso-
were subsequently washed six times with PBS/350 mM NaCl (pHmal snRNP biogenesis. It is particularly intriguing that
7.4), and the bound fraction was eluted by boiling in SDS-PAGEmotor neurons in the spinal cord contain an extremely
sample buffer.high concentration of SMN and SIP1 compared with
other tissues and that these cells also exhibit the most Cell Culture and Treatments
prominent gems and coiled bodies. However, in motor HeLa cells and NIH 3T3 cells were cultured in Dulbecco's modified
neurons of SMA type I patients, there are no detectable Eagle's medium (DMEM; GIBCO BRL, Gaithersburg, MD) supple-
gems, while coiled bodies appear normal (Lefebvre et mented with 10% FCS (GIBCO BRL). Low temperature incubations
were carried out as follows. HeLa cells were shifted to 328C andal., 1997). Thus, motor neurons probably have a very
incubated for 24 hr prior to fixation and permeablization for immuno-high requirement for SMN and gems, and these cells
staining. For actinomycin D treatment, HeLa cells were incubatedmay, therefore, be most sensitive to reduced amounts
with 5 mg/ml of actinomycin D for 3 hr before fixation for immuno-of the protein or to mutations in it, which result in their
staining. For in vivo labeling with [35S]methionine, 50% confluent
degeneration. It is, however, also possible that SMN has HeLa cells growing in 100 mm plates were incubated with 10 mCi/
a specific function in motor neurons. In this vein, we ml [35S]methionine in DMEM without methionine and supplemented
note that there is a neuronal-specific Sm protein, the with 10% FCS overnight before homogenization for immunoprecipi-
tation.SmN protein (Latchman, 1990).
Immunoprecipitation and ImmunoblottingExperimental Procedures
Immunoprecipitation of in vitro translated SIP1 protein was carried
out in the presence of 1% Empigen BB buffer as previously de-Yeast Two-Hybrid Screening
scribed (Choi and Dreyfuss, 1984). Immunoprecipitation and purifi-The human HeLa cDNA library, yeast strains, and yeast plasmids
pGBT9, pGADGH, pVA3, and pTD1 were from Clontech, Inc. The cation of the SMN complex was carried out using total HeLa lysate
Cell
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in the presence of 0.5% TritonX-100 as previously described (PinÄol- antibody, Dr. Joan A. Steitz for the anti-Sm Y12 monoclonal anti-
body, and Dr. Joseph Craft for the anti-fibrillarin antibodies. WeRoma et al., 1988). For immunoblotting, proteins were resolved on
a 12.5% SDS-polyacrylamide gel and transferred to nitrocellulose thank Dr. Reinhard LuÈ hrmann and VeronicaRaker for purified snRNP
proteins and plasmids. We thank Dr. Peter Bannerman and Tracymembrane (Schleicher and Schuell, Inc., Keene, NH) using a Bio-
Trans Model B Transblot apparatus (Gelman Science) according to Oliver for help with the confocal microscopy. We are grateful to
members of our laboratory for stimulating discussions and, in partic-the instructions of the manufacturer. Filters were incubated in blot-
ting solution (PBS, 5% nonfat milk) for at least 1 hr at room tempera- ular, Drs. Paul Eder, W. Matthew Michael, Sara Nakielny, Victoria
Pollard, and Haruhiko Siomi for helpful discussionsand critical com-ture, rinsed with cold PBS, and then incubatedwith primary antibody
for at least 1 hr at room temperature. Filters were washed three ments on this manuscript. U. F. received an AIDS scholarship and
a grant from the Deutsche Forschungsgemeinschaft (SFB 286). Thistimes in PBScontaining 0.1% Tween 20, and bound antibodies were
detected using the peroxidase-conjugated goat anti-mouse IgG plus work was supported by the Howard Hughes Medical Institute and
by a grant from the National Institute of Health.IgM (Jackson ImmunoResearch Laboratories). The protein bands
were visualized by an ECL Western blotting detection kit (Amer-
sham) after washing three times in PBS containing 0.1% Tween 20. Received April 11, 1997; revised August 7, 1997.
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